BlackBio signs JV agreement in India to develop, manufacture and commercialize new integral solutions for diagnostics

27-Oct-2010 - India

2B BlackBio, S.L. has signed with its local partner in India, Kilpest Ltd an agreement to participate in the `recently established joint venture between Kilpest and Biotools B&M Labs, S.A., renamed now as 3B BlackBio Biotech India Ltd´. With this agreement the new JV with laboratories in Bhopal, and Headquarters in Mumbai, India, will manufacture and develop integral solutions in the area of Personalized medicine and will offer diagnostic tests to predict drug treatment effectiveness (Companion Diagnostics), providing technologies to participate in the present exponential development of the Indian Pharma sector.

Together with a network of local Pharma companies, hospitals and clinical labs, the new Joint Venture will introduce into India an innovative site‐directed microsequencing platform that combines ease of use, specifity and cost competitiveness, allowing the introduction of companion diagnostics to one of the biggest global Healthcare markets.

Other news from the department business & finance

These products might interest you

Whatman™ folded filter papers

Whatman™ folded filter papers by Cytiva

Whatman folded filter papers

Convenient folded formats speed up your sample preparation

filter papers
Systec H-Series

Systec H-Series by Systec

Safe, reproducible and validatable sterilization of liquids, solids and waste

Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

laboratory autoclaves
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures